![]() |
市場調查報告書
商品編碼
1691679
慢性病電療法的創新與成長機會Innovations and Growth Opportunities in Electroceuticals for Chronic Diseases |
電療法是一個快速發展的領域,它尋求新的和創新的解決方案來克服治療各種疼痛和神經病變的挑戰。這些領域的新興技術正引起人們的極大興趣,因為它們有可能徹底改變該領域,為電療行業的技術開發人員創造有希望的產品開發機會。但這項技術創新面臨非選擇性、侵入性、開放回路、資料外洩風險等重大挑戰。因此,新興電醫療技術的大部分研發活動主要集中在將人工智慧融入穿戴式裝置上。
隨著非成癮性、非鴉片類藥物的個人化治療方法的興起,人們的治療方法從傳統反應性藥物轉向現代預防性電療法。與藥物相比,這些藥物可以實現早期療育和更長期的疾病控制。
本報告指出了電療產業正在採用的超越傳統醫藥和藥物的新技術。脊髓刺激、周邊神經刺激和經顱磁刺激分別被廣泛用於治療慢性疼痛和神經系統疾病,隨著穿戴式電動醫療設備、封閉回路型神經調節和個人化等新興概念的出現,本報告探討了新興技術在該行業的潛在優勢和劣勢。
Transforming Chronic Disease Management Through Advanced Neuromodulation Technologies
Electroceuticals is a rapidly growing field that is pursuing new and innovative solutions to overcome challenges in treating various pain and neurological disorders. Emerging technologies in these areas attract significant interest because of their potential to revolutionize the field, creating promising opportunities for technology developers in the electroceutical industry for product development. However, the innovations face significant challenges, including non-selectivity, invasiveness, open-loop, and risk of data breach. As a result, most R&D activities in emerging electroceutical technologies mainly focus on incorporating AI in wearables.
Questions this report answers: What are the emerging technologies gaining prominence in pain and neurological disorders management in the electroceutical space? What are the advantages and disadvantages driving R&D efforts in these modalities? Who are the major stakeholders targeting the adoption of these emerging modalities? What are the growth opportunities for electroceuticals in pain and neurological disorder management and the MedTech industry in the future?
With the rise in non-addictive, non-opioid-based personalized treatment approaches, there is an adoption shift from traditional reactive pharmaceuticals to modern preventative electroceuticals. Compared to pharmaceutical drugs, these have enabled early intervention and long-term disease management. The primary focus of the study is to identify the emerging technologies witnessing adoption across the electroceutical industry that will surpass conventional drugs and pharmaceuticals. Because of the wide adoption of Spinal Cord Stimulation, Peripheral Nerve Stimulation, and Transcranial Magnetic Stimulation for treating chronic pain and neurological conditions, respectively, and the emerging concepts of wearable electroceutical devices, closed-loop neuromodulation, and personalization, this study discusses the potential advantages and disadvantages of emerging technologies in the industry.